ABSI
No price yet
Announcements
Nothing here yet
Daily updates
Nothing here yet
FDA designations
Nothing here yet
News
- Absci announces preliminary design details for the Phase 2 STORYLINE trial of AI-designed antibody ABS-201 for endometriosisSep 24, 2026
- Absci reported positive interim Phase 1 results from the HEADLINE trial of ABS-201Jun 24, 2026
- Absci reports new ex vivo human data showing ABS-201™ stimulates hair growth and regenerates stem cell nicheDec 11, 2025
- Absci announces first participants dosed in Phase 1/2a HEADLINE™ trial of AI-designed ABS-201™ for androgenetic alopeciaDec 4, 2025